Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump

Brief description of study

The HeartMate 3 requires medicines to keep your blood from clotting knowing as “blood thinners” which can both be anticoagulants and antiplatelet drugs. The standard drugs given when you have the HeartMate 3 are warfarin and aspirin. This study is investigating whether the combination of these drugs as compared to warfarin alone causes more bleeding without the benefit of preventing more blood clots.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Heart Failure
  • Age: - 99 Years
  • Gender: All

Subject will HeartMate

Updated on 03 Apr 2024. Study ID: 843216

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center